source
- STAT+: Pharmalittle: We’re reading about the 340B drug pilot program, an obesity drug disappointment, and moreThe U.S. approved 10 drugmakers to participate in a 340B pilot program that will allow them to offer rebates, instead of upfront discounts, to certain providersSTAT · 19d ago↗ source
- Novartis bets up to $7.8B for an mRNA-encoded T cell engager from China’s AbogenNovartis is licensing an mRNA-based therapy designed to produce a CD3xCD19 T cell engager inside the body. Abogen Biosciences says the in vivo approach could reduce the likelihood of dangerous cyto…BioSpace · 19d ago↗ source
- Medicare Advantage plans to raise out-of-pocket costs and cut benefits for 2027 enrolleesMedicare Advantage insurers are set to increase out-of-pocket expenses for seniors enrolling in 2027 plans. The changes include higher cost‑sharing, reduced coverage for dental and other services,…